These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 6208997

  • 1. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
    Lee FH, Currie D, Hwang KM.
    Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S, Yamamoto H, Fujii Y, Arai S.
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [Abstract] [Full Text] [Related]

  • 3. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV, Pettey CL, Collins JJ.
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [Abstract] [Full Text] [Related]

  • 4. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA, Shu S, Chou T, Perry-Lalley D, Chang AE.
    J Immunol; 1988 Aug 01; 141(3):1047-53. PubMed ID: 3260908
    [Abstract] [Full Text] [Related]

  • 5. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T, Shu S.
    J Immunol; 1987 Sep 15; 139(6):2103-9. PubMed ID: 2957448
    [Abstract] [Full Text] [Related]

  • 6. MHC-unrestricted transfer of antilisterial immunity by freshly isolated immune CD8 spleen cells.
    Lukacs K, Kurlander RJ.
    J Immunol; 1989 Dec 01; 143(11):3731-6. PubMed ID: 2479688
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H, Fujiwara H, Takai Y, Izumi Y, Sano S, Tsuchida T, Hamaoka T.
    J Immunol; 1985 Sep 01; 135(3):2199-205. PubMed ID: 3894520
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES.
    J Immunol; 1986 Feb 15; 136(4):1510-5. PubMed ID: 3080526
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY, Howard JG, Hale C.
    J Immunol; 1984 Jan 15; 132(1):456-61. PubMed ID: 6228580
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S, Krinock RA, Matsumura T, Sussman JJ, Fox BA, Chang AE, Terman DS.
    J Immunol; 1994 Feb 01; 152(3):1277-88. PubMed ID: 8301131
    [Abstract] [Full Text] [Related]

  • 17. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS, Huston K, Shaw M, Tse HY, Raine CS.
    Lab Invest; 1994 Nov 01; 71(5):671-9. PubMed ID: 7526038
    [Abstract] [Full Text] [Related]

  • 18. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC, Paul RD, Lopez DM.
    J Natl Cancer Inst; 1984 Jul 01; 73(1):249-55. PubMed ID: 6610791
    [Abstract] [Full Text] [Related]

  • 19. Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells.
    Greenberg PD, Cheever MA.
    J Immunol; 1984 Dec 01; 133(6):3401-7. PubMed ID: 6149246
    [Abstract] [Full Text] [Related]

  • 20. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB, Ye QW.
    Cancer Res; 1985 Oct 01; 45(10):4932-9. PubMed ID: 4027979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.